Arteris (AIP) files Form 144 to sell 1,554 shares on 10/03/2025

Arteris, Inc. filed a Form 144 disclosing a proposed sale of 1,554 common shares to be executed through Morgan Stanley Smith Barney LLC on 10/03/2025 on NASDAQ.

Rhea-AI Filing Summary

Arteris, Inc. filed a Form 144 disclosing a proposed sale of 1,554 common shares to be executed through Morgan Stanley Smith Barney LLC on 10/03/2025 on NASDAQ. The filing states these shares were acquired as Restricted Stock Units from the issuer on 10/01/2025 and were paid/settled on the same date. The filing also lists multiple consummated sales by Laurent Moll during the prior three months, including sales of 42,692 shares on 09/02/2025 and other 10b5-1 plan sales totaling tens of thousands of shares across July–October 2025. The company reports 42,649,917 shares outstanding, and the proposed sale represents a small fraction of that total.

Insights

Compliance & SEC Filings Specialist

Form 144 discloses an insider sale and recent 10b5-1 plan transactions.

The filing shows a proposed sale of 1,554 shares on 10/03/2025 executed through Morgan Stanley Smith Barney LLC, with the shares acquired as Restricted Stock Units on 10/01/2025. This is a routine insider disclosure required under Rule 144 to report intended resale of restricted or control securities.

The filing also documents multiple completed sales by Laurent Moll under a 10b5-1 plan, including a 42,692-share sale on 09/02/2025, which indicates ongoing pre-arranged disposition activity rather than ad hoc trading.

Investor Relations Analyst

The disclosed amounts are small relative to total shares outstanding.

With 42,649,917 shares outstanding, the proposed 1,554-share sale and individual prior sales represent a minor percentage of the float. The filing therefore signals compliance and liquidity activity but does not, by itself, indicate a material change to company capitalization.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Arteris (AIP) disclose in the Form 144?

The filing discloses a proposed sale of 1,554 common shares via Morgan Stanley Smith Barney LLC on 10/03/2025, acquired as Restricted Stock Units on 10/01/2025.

Who conducted recent sales reported in the filing for AIP?

The filing lists multiple sales by Laurent Moll, including a 42,692-share sale on 09/02/2025 and other 10b5-1 plan sales between July and October 2025.

How many Arteris (AIP) shares are outstanding per the filing?

The filing shows 42,649,917 shares outstanding.

Were the shares being sold restricted or freely tradable?

The 1,554 shares proposed for sale were acquired as Restricted Stock Units on 10/01/2025, as stated in the filing.

Through which broker will the proposed sale be executed?

The proposed sale of 1,554 shares is listed to be executed through Morgan Stanley Smith Barney LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001888601
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Arteris, Inc.
SEC File Number	001-40960
Address of Issuer	900 E. Hamilton Ave., Suite 300 Campbell CALIFORNIA 95008
Phone	4084707300
Name of Person for Whose Account the Securities are To Be Sold	LAURENT MOLL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1554	17498.04	42649917	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Units	Issuer			1554	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	19060	209484.65
LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	4702	51349.60
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	151	1300.11
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	8129	71075.10
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/05/2025	4698	41363.54
LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	42692	381739.06
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	34400	466763.28
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/29/2025	736	8022.40

144: Remarks and Signature

Remarks
Date of Notice	10/03/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Laurent Moll
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)